Hong Kong’s PHASE Scientific raises $34M Series A round to advance urine-based diagnostic technology for early disease detection
PHASE Scientific International Limited, a Hong Kong-based biotechnology company, announced Tuesday the successful completion of a $34 million Series A funding round. The firm said in a statement that this represents the largest Series A raise in Asia’s diagnostic technology sector since 2019, reflecting robust investor conviction in PHASE Scientific’s innovative PHASIFY™...
0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Commandité
Commandité
Ifvex https://ifvex.com